Saba Capital Management, L.P. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 54 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Saba Capital Management, L.P. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$52,711
-50.0%
756,2530.0%0.00%
-66.7%
Q2 2023$105,384
+63.9%
756,2530.0%0.00%
+200.0%
Q1 2023$64,282
+84.6%
756,2530.0%0.00%
Q4 2022$34,825
-68.1%
756,2530.0%0.00%
-100.0%
Q3 2022$109,000
+31.3%
756,2530.0%0.00%0.0%
Q2 2022$83,000
-51.2%
756,2530.0%0.00%
-50.0%
Q1 2022$170,000756,2530.00%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 200,049$2,007,0000.05%
Q Global Advisors, LLC 195,489$18,0000.01%
RAMIUS ADVISORS LLC 196,073$16,0000.01%
EHP Funds Inc. 137,276$20,0000.00%
Telemetry Investments, L.L.C. 33,303$3,0000.00%
MARSHALL WACE, LLP 190,150$1,930,0000.00%
PERISCOPE CAPITAL INC. 735,572$97,0000.00%
Spartan Fund Management Inc. 75,000$11,0000.00%
Union Square Park Capital Management, LLC 25,000$2,0000.00%
KIM, LLC 250,000$36,0000.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders